Brief report · 29 Dec 2025
Conference abstractPublished 24 Mar 2014
Metabolomic profiling reveals potential markers and bioprocesses altered in bladder cancer progression
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Although alterations in xenobiotic metabolism are considered causal in the development of bladder cancer, theprecise mechanisms involved are poorly understood. In this study, we used high-throughput mass spectrometryto measure over 2,000 compounds in 58 clinical specimens, identifying 35 metabolites which exhibited significantchanges in bladder cancer. This metabolic signature distinguished both normal and benign bladder from bladdercancer. Exploratory analyses of this metabolomic signature in urine showed promise in distinguishing bladdercancer from controls and also nonmuscle from muscle-invasive bladder cancer. Subsequent enrichment-basedbioprocess mapping revealed alterations in phase I/ II metabolism and suggested a possible role for DNAmethylation in perturbing xenobiotic metabolism in bladder cancer. In particular, we validated tumor-associatedhypermethylation in the cytochrome P450 1A1 (CYP1A1) and cytochrome P450 1B1 (CYP1B1) promoters of bladdercancer tissues by bisulfite sequence analysis and methylation-specific PCR and also by in vitro treatment of T-24bladder cancer cell line with the DNA demethylating agent 5-aza-20-deoxycytidine. Furthermore, we showed thatexpression of CYP1A1 and CYP1B1 was reduced significantly in an independent cohort of bladder cancer specimenscompared with matched benign adjacent tissues. In summary, our findings identified candidate diagnostic andprognosticmarkers and highlightedmechanisms associatedwith the silencing of xenobioticmetabolism. Themetabolomicsignature we describe offers potential as a urinary biomarker for early detection and staging of bladdercancer, highlighting the utility of evaluating metabolomic profiles of cancer to gain insights into bioprocessesperturbed during tumor development and progression..
Subjects
Biochemistry & BiotechnologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Metabolomics:Open Access.
Perspective · 29 Dec 2025
Metabolomics: Assessing Environmental Health and Risk
Brief report · 29 Dec 2025
Metabolite Quantification: Accuracy, Standards, Applications
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalMetabolomics:Open Access
- SubjectBiochemistry & Biotechnology
- BylineArticles whose byline prints “Nagireddy Putluri”
